Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGames Workshop Regulatory News (GAW)

Share Price Information for Games Workshop (GAW)

Share Price is delayed by 15 minutes
Get Live Data
19,250.00    230.00 (1.21%)
Bid:
19,070.00
Ask:
19,090.00
Spread: 20.00 (0.105%)
Market Cap: £6.36b
GAW Live PriceLast checked at - London Stock Exchange

Intraday Games Workshop Share Chart

Result of Placing in Games Workshop Group PLC

27 Sep 2018 18:31

RNS Number : 2466C
Games Workshop Group PLC
27 September 2018
Β 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) ("MAR") No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

NOT FOR DISTRIBUTION IN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS), CANADA, JAPAN, AUSTRALIA OR THE REPUBLIC OF SOUTH AFRICA. THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

Β 

27 September 2018

Β 

Β 

Result of Placing of approximately Β£20 million of ordinary shares in Games Workshop Group PLC ("Games Workshop" or the "Company")

Β 

Further to the announcement made earlier today in relation to a proposed placing of ordinary shares in Games Workshop by ex-Chairman Tom Kirby (the "Seller"), the Seller announces that he has sold 556,301 ordinary shares (the "Placing Shares") in the Company at Β£36.50 per share (the "Placing"). The Placing Shares represent in aggregate approximately 1.7 per cent of the Company's issued share capital.

Β 

The Seller will continue to hold in aggregate approximately 4.8 per cent of the issued share capital of the Company. The Seller has agreed to a customary lock-up on his remaining shares which ends 180 days after the completion of the Placing.

Β 

The Placing was conducted through an accelerated bookbuild. Peel Hunt LLP (the "Bookrunner") acted as sole bookrunner for the Seller in connection with the Placing.

Β 

The proceeds of the Placing are payable in cash and will be settled on a T+2 basis (unless otherwise agreed with the Bookrunner), and settlement of the Placing is expected to occur on or about 02 October 2018.

Β 

The Company is not party to the Placing and, as a result, the Company will not receive any proceeds from the Placing.

Β 

For further information, please contact:

Β 

Peel Hunt LLP

+44 (0) 20 7418 8900

ECM:

Rory James-Duff

Sohail Akbar

Corporate:

Adrian Trimmings

Β 

DISCLAIMER

This announcement and the information contained herein may not be published, distributed or transmitted, directly or indirectly, in the United States (including its territories and possessions), Canada, Australia, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement and the information contained herein are for information purposes only and do not constitute or form part of any offer of securities for sale or a solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction.

The Placing Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under the applicable securities laws of any state or other jurisdiction of the United States, Canada, Australia, the Republic of South Africa or Japan or of any other jurisdiction. The Placing Shares may not be offered or sold in the United States unless registered under the US Securities Act or offered in a transaction exempt from, or not subject to, the registration requirements of the US Securities Act and the securities laws of any relevant state or other jurisdiction of the United States. There will be no public offering of the Placing Shares in the United States or elsewhere.

In the United Kingdom, this announcement is only directed at persons who are qualified investors (as defined below) and (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). This announcement is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

In member states of the European Economic Area (EEA) which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive. For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU.

The distribution of this announcement and the offering or sale of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken that would permit an offering of securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions. No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by the Seller, Peel Hunt LLP or any of their respective affiliates.

Peel Hunt LLP is authorised and regulated by the Financial Conduct Authority in the United Kingdom. The Bookrunner is acting only for the Seller in connection with the Placing and will not be responsible to anyone other than the Seller for providing the protections offered to their respective clients nor for providing advice in relation to the Placing or any matters referred to in this announcement.

Β 

In connection with any offering of the Placing Shares, Peel Hunt LLP and/or any of its affiliates may take up a portion of the securities in the offering as a principal position and in that capacity may retain, purchase or sell for their own account such securities. Peel Hunt LLP do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IOEDDLFLVKFLBBK
Date   Source Headline
1st Jun 20263:43 pmRNSHolding(s) in Company
1st Jun 20262:01 pmRNSTotal Voting Rights
22nd May 20267:00 amRNSTrading Statement
11th May 20267:00 amRNSDirectorate Change
1st May 202610:35 amRNSTotal Voting Rights
13th Apr 20264:36 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20261:32 pmRNSAdmission of Further Securities to Trading
19th Mar 202612:43 pmRNSDirector/PDMR Shareholding
11th Mar 20263:58 pmRNSDirector/PDMR Shareholding
11th Mar 20263:58 pmRNSDirector/PDMR Shareholding
5th Mar 202612:54 pmRNSResult of Meeting
2nd Mar 20265:11 pmRNSBlock Listing Six Monthly Return
2nd Mar 20265:02 pmRNSTotal Voting Rights
10th Feb 20267:00 amRNSPublication of Notice Convening a General Meeting
2nd Feb 20265:01 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSDirector Shareholdings
13th Jan 20267:01 amRNSDividend
13th Jan 20267:00 amRNSHalf-Yearly Report
2nd Jan 202612:14 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSDirectorate change
19th Dec 20257:00 amRNSDirectorate change
17th Dec 20257:00 amRNSDividend
1st Dec 202510:14 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirectorate change
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:01 amRNSDividend
20th Nov 20257:00 amRNSTrading Update
10th Nov 20254:23 pmRNSHolding(s) in Company
28th Oct 202512:16 pmRNSTotal Voting Rights
7th Oct 20252:45 pmRNSDirector Shareholding
1st Oct 20253:13 pmRNSTotal Voting Rights
1st Oct 20259:42 amRNSDisclosure of New Directorship
17th Sep 20252:01 pmRNS2025 AGM Voting Results
17th Sep 20257:00 amRNSDividend
1st Sep 20252:00 pmRNSBlock Listing Six Monthly Return
1st Sep 202510:21 amRNSTotal Voting Rights
18th Aug 20251:46 pmRNSDirector Shareholdings
4th Aug 20257:00 amRNSDirector Shareholding
1st Aug 20251:49 pmRNSTotal Voting Rights
29th Jul 20257:01 amRNSDividend
29th Jul 20257:00 amRNSDirectorate Change
29th Jul 20257:00 amRNSAnnual Report
4th Jul 20252:24 pmRNSGrant of award under Share Awards Plan
2nd Jul 202511:59 amRNSTotal Voting Rights
25th Jun 20257:00 amRNSDividend
2nd Jun 20257:00 amRNSDirectorate Change
2nd Jun 20257:00 amRNSTotal Voting Rights
23rd May 20257:00 amRNSFull Year Trading Update
21st May 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.